These findings suggest that Fra-1 may activate the PPP metabolic pathway by stabilizing the protein level of G6PD, consequently reducing the cell proliferation ability and enhancing resistance to CDDP in GC cells. This evidence concerns the gene G6PD and gastric cancer.